What is the ticker symbol for ImmunoGen?

ImmunoGen trades under the ticker IMGN on NASDAQ.

What sector does ImmunoGen operate in?

ImmunoGen is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze IMGN in a portfolio?

PortView shows IMGN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

ImmunoGen (IMGN) Stock Analysis

NASDAQHealthcareBiotechnology

$31.24+0.02%

1-year price historyRange $3.67 – $31.23

52-week range$31.24

$3.61$31.25

What ImmunoGen does

ImmunoGen, Inc. is a clinical-stage biotechnology enterprise that specializes in the creation of antibody-drug conjugate (ADC) therapies for cancer treatment. A prominent drug in their pipeline is mirvetuximab soravtansine, an ADC designed to target folate-receptor alpha (FRa), which is currently undergoing Phase III clinical trials for patients with platinum-resistant ovarian cancer. Another significant candidate, Pivekimab sunirine, a CD123-targeting ADC, is progressing through Phase II studies for acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Beyond its clinical efforts, the company's preclinical portfolio includes IMGC936, an ADC being co-developed with MacroGenics, Inc., and IMGN151, another anti-FRa therapeutic. ImmunoGen maintains strategic collaborations with a range of key industry players, such as Roche, Amgen/Oxford BioTherapeutics, Bayer HealthCare AG, Eli Lilly and Company, Novartis Institutes for BioMedical Research, Inc., CytomX Therapeutics, Inc., Fusion Pharmaceuticals Inc., Debiopharm International SA, and MacroGenics, Inc. Founded in 1980, ImmunoGen, Inc. is headquartered in Waltham, Massachusetts.

Key metrics

Market cap

$8.73B

P/E (TTM)

-111.55

EPS (TTM)

$-0.28

Beta

1.17

Dividend yield

0.00%

Revenue / share

$0.43

50-day avg

$29.04

200-day avg

$18.87

52-week high

$31.25

52-week low

$3.61

CEO

Mark Joseph Enyedy

ETFs linked to IMGN

Broad-market and Healthcare sector ETFs an investor holding ImmunoGen is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how IMGN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze IMGN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for ImmunoGen?: ImmunoGen trades under the ticker IMGN on NASDAQ.
Which exchange is IMGN listed on?: IMGN is listed on NASDAQ.
What sector does ImmunoGen operate in?: ImmunoGen is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze IMGN in a portfolio?: PortView shows IMGN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.